Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats

Inflammopharmacology

Volumn 20, Issue 2, 2012, Pages 89-97

  Taliyan, Rajeev ^a,b   Sharma, Pyare Lal ^a  

^a ISF COLLEGE OF PHARMACY   (India)

^b KRISHNA INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

Hyperalgesia; Hyperglycemia; Neuropathic pain; Nitric oxide; Spleen homogenate supernatant (SHS); Streptozotocin (STZ)

Indexed keywords

GLUCOSE; MORPHINE; NITRIC OXIDE; NITRITE; STREPTOZOCIN; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANALGESIA; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DYNAMIC ANESTHESIOMETER; EXPERIMENTAL TEST; FEMALE; GLUCOSE BLOOD LEVEL; HYPERALGESIA; MALE; MECHANICAL ALLODYNIA; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PAW WITHDRAWAL TEST; PRIORITY JOURNAL; RAT; SPLEEN HOMOGENATE; STREPTOZOCIN DIABETES; SUPERNATANT; TAIL FLICK TEST; THERMAL HYPERALGESIA; TISSUE HOMOGENATE; URINALYSIS;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FEMALE; HYPERALGESIA; MALE; MORPHINE; NEURALGIA; NITRITES; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, WISTAR; SPLEEN; SPLENECTOMY; STREPTOZOCIN; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863109879     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-011-0106-4     Document Type: Article

References (49)

1. Ahmed AZO, Moustafa HM, Saida ALY, Randa ADH, Samy AR (2006) Attenuation of morphine tolerance and dependence by aminoguanidine in mice. Eur J Pharmacol 540:60-66.
2. Calcutt NA, Backonja MM (2007) Pathogenesis of pain in peripheral diabetic neuropathy. Curr Diabetes Rep 7:429-434.
3. Cameron NE, Cotter MA (2008) Pro-inflammatory mechanis neuropathy: focus on the nuclear factor kappa B pathway. Curr Drug Targets 9(1):60-67.
4. Chen SR, Samoriski G, Pan HL (2009) Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain. Neuropharmacology 257(2):121-126.
5. Courteix C, Bardin M, Chantelauze C, Lavarenne J, Eschalier A (1994) Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain 57(2):153-160.
6. Courteix C, Bourget P, Caussade F, Bardin M, Coudore F, Fialip F, Eschalier A (1998) Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics? J Pharmacol Exp Ther 285:63-70.
7. D'Amour WL, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
8. Deng W, Theil B, Tannenbaum CS, Hamilton TA, Stuehr DJ (1993) Synergistic co-operation between T cell lymphokines for induction of nitric oxide synthase in murine peritoneal macrophages. J Immunol 151:322-329.
9. Doupis J, Lyons Thomas E, Szuhuei Wu, Charalambos G, Thanh D, Aristidis V (2009) Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab 94:2157-2163.
10. Empl M, Renaud S, Erne B, Fuhr P, Straube A, Schaeren-Wiemers N, Steck AJ (2001) TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56(10):1371-1377.
11. Gonzalez-Clemente JM, Mauricio D, Richart C, Broch M, Caixàs A, Megia A, Giménez-Palop O, Simón I, Martínez-Riquelme A, Giménez-Pérez G, Vendrell J (2005) Diabetic neuropathy is associated with activation of the TNF-a system in subjects with type 1 diabetes mellitus. Clin Endocrinol 63(5):525-529.
12. Green LC, Wagner DA, Glogowski J (1982) Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 126(1):131-138.
13. Grover VS, Sharma A, Singh M (2000) Role of nitric oxide in diabetes-induced attenuation of antinociceptive effect of morphine in mice. Eur J Pharmacol 399:161-164.
14. Guo LZ, Ye HW, Hui LT, Zhi BL (2001) Effect of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes. World J Gastroenterol 7(3):331-334.
15. Hargreaves KM, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
16. Hide I, Tanaka M, Inoue A (2000) Extracellular ATP triggers tumor necrosis factor alpha release from rat microglia. J Neurochem 75:965-972.
17. Ibironke GF, Saba OJ (2006) Effect of hyperglycemia on the efficacy of morphine analgesia in rats. Afr J Med Sci 5(4):443-445.
18. Jana HL, Daniel JC, Douglas GM, Richard CM (1999) Effect of hyperglycemia on pain threshold in alloxan-diabetic rats. Pain 40(1):105-107.
19. Joharchi K, Jorjani M (2007) The role of nitric oxide in diabetesinduced changes of morphine tolerance in rats. Eur J Pharmacol 570(1-3):66-71.
20. Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, Leinwand L, Maier SF, Watkins LR (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 24(33):7353-7365.
21. Juan PC, Han-Rong W, Patrick MD (2008) The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res 1229:100-110.
22. Kamei J, Kawashima N, Kasuya Y (1992) Role of spleen or spleen products in the deficiency in morphine-induced analgesia in diabetic mice. Brain Res 576(1):139-142.
23. Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y (1994) Evidence for differential modulation of l-opioid receptormediated antinociceptive and antitussive activities by spleenderived factor(s) from diabetic mice. Neuropharmacol 33(12): 1553-1558.
24. Kolb H, Kroncke KD (1993) IDDM: lessons from the low-dose streptozotocin model in mice. Diabetes Rev 1:116-126.
25. Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: a new model of diabetes mellitus. Science 193:415-417.
26. Ling YU, Fu-Shan Xue, Li CW, Xu Ya-Chao, Guo-Hua Z, Kun-Peng L, Yi L, Hai-Tao S (2006) Nx-nitro-L-arginine methyl ester inhibits the up-regulated expression of neuronal nitric oxide synthase/NMDA receptor in the morphine analgesia tolerance rats. Acta Physiologica Sinica 58(6):593-598.
27. Maryam B, Zeinab K (2010) Short-and long-term modulation of microvascular responses in streptozotocin-induced diabetic rats by glycosylated products. J Diabetes Complicat 24:64-72.
28. Mika J, Osikowicz M, Makuch W, Przewlocka B (2007) Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol 560(2-3):142-149.
29. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, Tracey K, Martin D, Maier SF, Watkins LR (2003) Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23:1026-1040.
30. Monika E, Renaud S, Erne B, Fuhr P, Straube A, Schaeren-Wiemers N, Steck AJ (2001) TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56:1371-1377.
31. Obrosova IG, Drel VR, Oltman CL, Mashtalir N, Tibrewala J, Groves JT, Yorek MA (2007) Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab 293:E1645-E1655.
32. Oka M, Sakuma Y, Kato Y, Ueda Y (2002) Large dose of thalidomide are effective for inhibiting mechino-allodynia after the onset of neuropathic pain. J Osaka Dent Univ 36(2):113-117.
33. Raghavendra V, Rutkowski MD, DeLeo JA (2004) Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 29:327-334.
34. Raz I, Hasdai D, Seltzer Z, Melmed RN (1988) Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes 37:1253-1259.
35. Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G (1991) Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 173(3):699-703.
36. Satoh J, Yagihashi S, Toyota T (2003) The possible role of tumor necrosis factor-a in diabetic polyneuropathy. Exp Diabesity Res 4:65-71.
37. Schafer M (2009) Novel concepts for analgesia in severe pain-current strategies and future innovations. Eur J Pain Suppl 3(1):6-10.
38. Shingo Y, Yasuyuki S, Mitsutoshi Y, Yoshio K, Shuichi T, Satoshi W, Masaki A, Ken-ichi M (2006) Antinociceptive effect of methyl eugenol on formalin induced hyperalgesia in mice. Eur J Pharmacol 553:99-103.
39. Shukla KP, Tang L, Wang ZJ (2006) Phosphorylation of neurogranin, protein kinase C, and Ca2/calmodulin dependent protein kinase II in opioid tolerance and dependence. Neurosci Lett 404(3):266-269.
40. Smith LF, Lohmann AB, Dewey WL (1999) Involvement of phospholipid signal transduction pathways in morphine tolerance in mice. Br J Pharmacol 128:220-226.
41. Stanislava DS, Danijela DM, Marija BMS, Miodrag LL (2001) Pentoxifylline prevents autoimmune mediated inflammation in low dose streptozotocin induced diabetes. Devel Immunol 8(3-4):213-221.
42. Taliyan R, Singh M, Sharma PL (2010a) Beneficial effect of cyclosporine in experimental diabetes induced neuropathic pain in rats. Intern J Pharmacol 6(4):355-361.
43. Taliyan R, Singh M, Sharma PL (2010b) Possible mechanism of hyperglycemia induced decrease in antinociceptive effect of analgesics in rats. IJPSR 1(5):99-107.
44. Timothy SB, John WC (1997) The role of nuclear factor k B in cytokine gene regulation. Am J Respir Cell Mol Biol 17:3-9.
45. Tsiklauri N, Tsagareli MG (2006) Non-opioid-induced tolerance in rats. Neuropyhysiology 38:314-317.
46. Wei XH, Zang Y, Wu CY, Xu JT, Xin WJ, Liu XG (2007) Peri-sciatic administration of recombinant rat TNF-alpha induces mechanical allodynia via upregulation of TNF-alpha in dorsal root ganglia and in spinal dorsal horn: the role of NF-kappa B pathway. Exp Neurol 205(2):471-484.
47. Yu LN, Yang XS, Hua Z, Xie W (2009) Serum levels of proinflammatory cytokines in diabetic patients with peripheral neuropathic pain and the correlation among them. Zhonghua Yi Xue Za Zhi 89(7):469-471.
48. Ziegler D (2008) Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care 31(2):S255-S261.
49. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.